Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Strategy Briefing

The Future of Probiotics (Part Two): Chronic Disease and Science Versus Regulation

68 pages, Feb 2016

US$1,325

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

About This Report

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Chronic diseases are going to create a new leverage point for probiotic products, especially in the area of cardiovascular health and diabetes. Part two of this global briefing on probiotics aims to highlight where future growth in probiotics is to be found. It also reviews the regulatory status and shows how both permitting and banning health claims can have a strong impact on the marketplace.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Drinking yoghurt will drive absolute growth

Global probiotic yoghurt sales are set for another five years of strong growth, with a CAGR of 7% forecast between 2015 and 2020. Whilst drinking yoghurt will be key to that growth in absolute terms, the buoyant 85% rise in plain probiotic yoghurt will still be expected. Several key markets are set to see declines, though.

Invest in yoghurt in Asia, in supplements in North America and Western Europe

China will dominate growth in probiotic yoghurt between 2015 and 2020, with an increase of US$9.9 billion, while probiotic supplements in the US are set to rise by US$1 billion, and previously underperforming Japan will recover. Supplements are forecast to outperform yoghurt in absolute value terms in a number of key markets.

Restrictive regulatory environments constrain sales

Regulatory changes in the area of health claims have a strong impact on market performance. The EU probiotic claims ban is predicted to contribute to a revenue loss for probiotic yoghurt of around €2.5 billion between 2012 and 2020.

New science – new opportunities

Despite the lack of approved health claims beyond these broadly relating to digestion, probiotics undergo numerous studies and clinical trials, opening up further areas for development, including infant health and antimicrobial resistance. With digestive discomfort of key concern for the target group, there is also a clear gap in the market for “free-from” probiotic products.

Chronic disease: A prime opportunity for probiotics

Ultimately, the spread of chronic diseases, coupled with a sharp rise in the elderly population, will create a leverage point for a new generation of probiotics, especially in the area of cardiovascular health and diabetes.

Want to find out more about this report?

Request more information

Introduction

Scope of global briefing

Key findings

Objectives of Global Briefing

The microbiome and chronic disease

Chronic disease: A prime opportunity for probiotics

The microbiome as a therapeutic target

Modern lifestyles’ impact on microbiome triggers chronic disease

Probiotic hope for diabetes patients?

Alarming rise in diabetes prevalence in MEA and LA

Microbiome manipulation for effective weight management

Extra weight creates extra health risks

From the problem of the rich to the problem of the poor

Childhood obesity further fuels chronic diseases

Weight management probiotic products still thin on the ground

Probiotic yoghurt with stevia

Veggie probiotic yoghurts also benefit from sugar reduction

No sugar and no sweeteners added probiotic yoghurt?

Cardiovascular health: Another o pportunity f or p robiotics

Chocolate for cardiovascular health?

The fibre-microbiota-butyrate axis in tumour suppression

Sharp rise in the old-age market to fuel “affordable prevention”

Opportunities beyond chronic disease

Leveraging new trends as opportunities for probiotics

A gap in the market: Free-from probiotic products

Probiotics: A port of call for intolerance sufferers

Product diversification: Time to be brave? …Again?

Probiotic opportunities in pregnancy and lactation

Probiotics an innovation component in other baby food

Probiotic powder fights ear infections in babies

Cry baby blues: L. reuteri

A weapon in the fight against antimicrobial resistance (AMR)

The Regulatory environment

Do health claims matter? Yes, they do!

Regulatory environment varies greatly across the globe

EU regulatory update

Probiotics dominated those claims to disappear

Closed door for “probiotics”: Focus on well-documented strains or...

…reformulate and re-focus

Digestive wellness platform erodes in the EU

EU: Strict regulatory environment constrains sales

Let’s ask again: Do health claims matter?

Drinking probiotic yoghurt: Potential lost revenue up to €1.5 bn

Spoonable yoghurt: Potential lost revenue up to €1 bn

Switzerland, home of probiotic health claim approvals in Europe

Activia: Non-EU Switzerland versus the EU

Probiotic Supplements EU 20: Growth performance restored

Asia Pacific and Australasia among the most permissive

The US: A flexible but challenging market for probiotics

Outlook

Probiotics: From US$35 billion in 2015 to US$48 billion in 2020

Probiotic yoghurt player? Invest in Asia or Latin America

Forecast: China leads probiotic yoghurt growth markets

India: A future growth market for probiotic drinking yoghurt

Per capita expenditure highlights probiotic yoghurt’s potential

Numerous countries still spend under US$3 per capita

Probiotic supplements to hit US$5 billion by 2020

Forecast: US to add US$1 billion to global probiotic supplements

Probiotic supplements: Long-term growth potential

Probiotics: Invest in supplements or yoghurt?

Supplements the growth engine in the US, Italy and Russia

What should m anufacturers f ocus o n?

Appendix

A fast moving story…

Report terminology

Health and wellness category definitions

Health and wellness product coverage

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Strategy Briefing

The Future of Probiotics (Part Two): Chronic Disease and Science Versus Regulation

New Report Guarantee

About This Report

New Report Guarantee

Overview

Why buy this report?

Drinking yoghurt will drive absolute growth

Invest in yoghurt in Asia, in supplements in North America and Western Europe

Restrictive regulatory environments constrain sales

New science – new opportunities

Chronic disease: A prime opportunity for probiotics

Want to find out more about this report?

Table of Contents

Introduction

Scope of global briefing

Key findings

Objectives of Global Briefing

The microbiome and chronic disease

Chronic disease: A prime opportunity for probiotics

The microbiome as a therapeutic target

Modern lifestyles’ impact on microbiome triggers chronic disease

Probiotic hope for diabetes patients?

Alarming rise in diabetes prevalence in MEA and LA

Microbiome manipulation for effective weight management

Extra weight creates extra health risks

From the problem of the rich to the problem of the poor

Childhood obesity further fuels chronic diseases

Weight management probiotic products still thin on the ground

Probiotic yoghurt with stevia

Veggie probiotic yoghurts also benefit from sugar reduction

No sugar and no sweeteners added probiotic yoghurt?

Cardiovascular health: Another o pportunity f or p robiotics

Chocolate for cardiovascular health?

The fibre-microbiota-butyrate axis in tumour suppression

Sharp rise in the old-age market to fuel “affordable prevention”

Opportunities beyond chronic disease

Leveraging new trends as opportunities for probiotics

A gap in the market: Free-from probiotic products

Probiotics: A port of call for intolerance sufferers

Product diversification: Time to be brave? …Again?

Probiotic opportunities in pregnancy and lactation

Probiotics an innovation component in other baby food

Probiotic powder fights ear infections in babies

Cry baby blues: L. reuteri

A weapon in the fight against antimicrobial resistance (AMR)

The Regulatory environment

Do health claims matter? Yes, they do!

Regulatory environment varies greatly across the globe

EU regulatory update

Probiotics dominated those claims to disappear

Closed door for “probiotics”: Focus on well-documented strains or...

…reformulate and re-focus

Digestive wellness platform erodes in the EU

EU: Strict regulatory environment constrains sales

Let’s ask again: Do health claims matter?

Drinking probiotic yoghurt: Potential lost revenue up to €1.5 bn

Spoonable yoghurt: Potential lost revenue up to €1 bn

Switzerland, home of probiotic health claim approvals in Europe

Activia: Non-EU Switzerland versus the EU

Probiotic Supplements EU 20: Growth performance restored

Asia Pacific and Australasia among the most permissive

The US: A flexible but challenging market for probiotics

Outlook

Probiotics: From US$35 billion in 2015 to US$48 billion in 2020

Probiotic yoghurt player? Invest in Asia or Latin America

Forecast: China leads probiotic yoghurt growth markets

India: A future growth market for probiotic drinking yoghurt

Per capita expenditure highlights probiotic yoghurt’s potential

Numerous countries still spend under US$3 per capita

Probiotic supplements to hit US$5 billion by 2020

Forecast: US to add US$1 billion to global probiotic supplements

Probiotic supplements: Long-term growth potential

Probiotics: Invest in supplements or yoghurt?

Supplements the growth engine in the US, Italy and Russia

What should m anufacturers f ocus o n?

Appendix

A fast moving story…

Report terminology